日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Efficacy and safety of neoadjuvant camrelizumab and apatinib combined with chemotherapy in stage IIIA (N2) NSCLC: a multi-center, single-arm, phase II trial

新辅助卡瑞利珠单抗和阿帕替尼联合化疗治疗IIIA期(N2)非小细胞肺癌的疗效和安全性:一项多中心、单臂II期试验

Zhao, Lilan; Guo, Tianxing; Zhang, Yi; Huang, Zhen; Huang, Yangyun; Zhu, Lihuan; Chen, Xing; Zhang, Nan; Guo, Liren; Huang, Rongzhi; Geng, Guojun; Li, Ning; Chen, Shuxing; Pan, Xiaojie; Chen, Wenshu

Value of the 14-gene molecular assay in efficacy assessment of neoadjuvant chemoimmunotherapy for non-small cell lung cancer

14基因分子检测在非小细胞肺癌新辅助化疗免疫疗法疗效评估中的价值

Lan, Xuyan; Sun, Xiaoyu; Chen, Ruiqi; Zhu, Lihuan; Pan, Xiaojie; Guo, Tianxing

Synergistic Changes in Ascorbic Acid and Soluble Sugar Contents in Apricot Fruits and the Related Regulatory Mechanisms

杏果实中抗坏血酸和可溶性糖含量的协同变化及其相关调控机制

He, Yanhong; Zhao, Yang; Guo, Tianxing; Jia, Wenbao; Tian, Chun; Bai, Yu-E

The efficacy analysis of neoadjuvant chemoimmunotherapy followed by surgery in stage III locally advanced non-small cell lung cancer: a systematic review and meta-analysis

新辅助化疗联合免疫治疗后行手术治疗局部晚期III期非小细胞肺癌的疗效分析:系统评价和荟萃分析

Yang, Xiaojie; He, Yingqiu; Guo, Tianxing; Fang, Jiabin; Chen, Sufang; Zhang, Qiongyao; Lin, Ying; Xu, Nengluan; Pan, Xiaojie; Li, Hongru

The correlation of tertiary lymphoid structures with tumor spread through air spaces and prognosis in lung adenocarcinoma: focusing on pathological spatial features.

三级淋巴结构与肺腺癌肿瘤通过气腔扩散及预后的相关性:以病理空间特征为重点

Ding Yun, Yu Mengting, Xue Mengli, Zong Wenkang, Huang Yangyun, Ren Jie, Guo Tianxing, Sun Daqiang, Pan Xiaojie

Favorable outcomes with jejunal interposition without vascular anastomosis for esophagectomy in cancer patients: a single-center experience

食管癌患者行空肠间置术而不进行血管吻合可取得良好疗效:单中心经验

Zhao, Lilan; Ding, Yun; Zhang, Juan; Tu, Pengjie; He, Zijie; Li, Genglin; Lin, Zhaoxian; Lin, Xing; Lin, Zhiwei; Zhang, Zhenlong; Guo, Tianxing; Zhu, Lihuan; Chen, Wenshu; Ou, Debin; Pan, Xiaojie

Predictive value of DOT1L mutations for clinical outcomes in non-small-cell lung cancer patients receiving immune checkpoint inhibitor therapy

DOT1L突变对接受免疫检查点抑制剂治疗的非小细胞肺癌患者临床结局的预测价值

Guo, Tianxing; Wang, Zhaofeng; Wang, Song; Zhang, Yaru; Pang, Jiaohui; Ying, Yajun; Ou, Qiuxiang; Shen, Dong; Li, Gang

Correlation Analysis of the TP53 Mutation With Clinical Characteristics in the Prognosis of Non-Small Cell Lung Cancer

TP53突变与非小细胞肺癌预后临床特征的相关性分析

Zhu, Lihuan; Zhou, Dongsheng; Chen, Yiyong; Guo, Tianxing; Chen, Wenshu; Pan, Xiaojie

CircMMD_007 promotes oncogenic effects in the progression of lung adenocarcinoma through microRNA-197-3p/protein tyrosine phosphatase non-receptor type 9 axis

CircMMD_007 通过 microRNA-197-3p/蛋白酪氨酸磷酸酶非受体型 9 轴促进肺腺癌进展中的致癌作用。

Zhu, Lihuan; Guo, Tianxing; Chen, Wenshu; Lin, Zhaoxian; Ye, Mingfan; Pan, Xiaojie

Pembrolizumab combined with paclitaxel and platinum as induction therapy for locally advanced esophageal squamous cell carcinoma: a retrospective, single-center, three-arm study

帕博利珠单抗联合紫杉醇和铂类药物作为局部晚期食管鳞状细胞癌诱导治疗:一项回顾性、单中心、三组研究

Lin, Wenbao; Huang, Yangyun; Zhu, Lihuan; Li, Wujin; Zhao, Lilan; Pan, Xiaojie; Lin, Jinlan; Guo, Tianxing